CTOs on the Move

Abeo Management Corporation

www.abeo.com

 
abeo is a nationwide medical billing and software company focused on delivering revenue-enhancing services to private practices, hospitals and surgery centers. We bridge the gap between the constant change in healthcare and your changing needs as a result. We know the healthcare landscape; we know the complexities and regulations. Our professional management services, medical billing software and anesthesia advisory services are tailored to improve the operational and financial performance for the specialty of anesthesiology. We blend our employee expertise in anesthesia with process and technology to take efficiency to the next level. Operational best practices play a key role in our ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.abeo.com
  • 5001 LBJ Freeway Suite 320
    Dallas, TX USA 75244
  • Phone: 972.861.1270

Executives

Name Title Contact Details
Joe Ferro
Chief Technology and Innovation Officer Profile

Similar Companies

Cancer Nutrition Centers

Cancer Nutrition Centers is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

STATPROBE

STATPROBE is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Valencell

Valencell develops performance biometric sensor technology and provides this patent-protected technology to consumer electronics manufacturers, wearable and hearable device makers, sports and fitness brands, medical device makers, and gaming companies for integration into their products.

Charlotte Community Mental Health Services

Charlotte Community Mental Health Services is a Punta Gorda, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.